Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Rosini

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2016
The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal SeraMonica Fabbrini, Fabio Rigat, C Daniela Rinaudo, et al.
FEMS Microbiology Letters|July 29, 2016
A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypesRicardo Monteiro, Valentin Ageorges, Maricarmen Rojas-Lopez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 19, 2012
New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assemblyRoberta Cozzi, Annalisa Nuccitelli, Mariapina D'Onofrio, et al.
Plos One|May 7, 2015
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus populationRoberto Rosini, Edmondo Campisi, Matteo De Chiara, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2009
Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1Francesco Doro, Sabrina Liberatori, Manuel J Rodríguez-Ortega, et al.
The Journal of Infectious Diseases|December 18, 2008
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigmImmaculada Margarit, Cira Daniela Rinaudo, Cesira L Galeotti, et al.
Mbio|April 13, 2012
FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infectionsBarbara Nesta, Glen Spraggon, Christopher Alteri, et al.
Mbio|July 25, 2013
EsiB, a novel pathogenic Escherichia coli secretory immunoglobulin A-binding protein impairing neutrophil activationIlaria Pastorello, Silvia Rossi Paccani, Roberto Rosini, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changesAnthony R Flores, Jessica Galloway-Peña, Pranoti Sahasrabhojane, et al.
Plos Pathogens|May 10, 2014
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsBarbara Nesta, Maria Valeri, Angela Spagnuolo, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 13, 2016
The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal SeraMonica Fabbrini, Fabio Rigat, C Daniela Rinaudo, et al.
FEMS Microbiology Letters|July 29, 2016
A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypesRicardo Monteiro, Valentin Ageorges, Maricarmen Rojas-Lopez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 19, 2012
New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assemblyRoberta Cozzi, Annalisa Nuccitelli, Mariapina D'Onofrio, et al.
Plos One|May 7, 2015
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus populationRoberto Rosini, Edmondo Campisi, Matteo De Chiara, et al.
Molecular & Cellular Proteomics : MCP|April 30, 2009
Surfome analysis as a fast track to vaccine discovery: identification of a novel protective antigen for Group B Streptococcus hypervirulent strain COH1Francesco Doro, Sabrina Liberatori, Manuel J Rodríguez-Ortega, et al.
The Journal of Infectious Diseases|December 18, 2008
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigmImmaculada Margarit, Cira Daniela Rinaudo, Cesira L Galeotti, et al.
Mbio|April 13, 2012
FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infectionsBarbara Nesta, Glen Spraggon, Christopher Alteri, et al.
Mbio|July 25, 2013
EsiB, a novel pathogenic Escherichia coli secretory immunoglobulin A-binding protein impairing neutrophil activationIlaria Pastorello, Silvia Rossi Paccani, Roberto Rosini, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2015
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changesAnthony R Flores, Jessica Galloway-Peña, Pranoti Sahasrabhojane, et al.
Plos Pathogens|May 10, 2014
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsBarbara Nesta, Maria Valeri, Angela Spagnuolo, et al.
Pageof 5